![Daniel Couto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Couto
Geschäftsführer bei
Vedanta Biosciences, Inc.
Profil
Daniel E.
Couto is currently the Chief Operating Officer at Vedanta Biosciences, Inc. He previously worked as a Director at ImmuCell Corp., Sumitomo Pharma America, Inc., AFG Biosolutions, Inc., rEVO Biologics, Inc., and as the Vice President-Commercial Manufacturing Operations at Organon Pharma (UK) Ltd. He also served as the Senior Vice President-Product Development at ContraFect Corp.
from 2014 to 2016.
Couto completed his undergraduate degree from Rensselaer Polytechnic Institute.
Aktive Positionen von Daniel Couto
| Unternehmen | Position | Beginn |
|---|---|---|
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Geschäftsführer | 01.10.2019 |
Ehemalige bekannte Positionen von Daniel Couto
| Unternehmen | Position | Ende |
|---|---|---|
| CONTRAFECT CORPORATION | Corporate Officer/Principal | 22.04.2016 |
AFG Biosolutions, Inc.
 AFG Biosolutions, Inc. Pharmaceuticals: MajorHealth Technology Develops medical defenses against bio-terrorist agents | Direktor/Vorstandsmitglied | - |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Direktor/Vorstandsmitglied | - |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales women's health products | Corporate Officer/Principal | - |
| IMMUCELL CORPORATION | Direktor/Vorstandsmitglied | - |
Ausbildung von Daniel Couto
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
23
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
ImmuCell Corp.
 ImmuCell Corp. BiotechnologyHealth Technology Develops and provides products for cattle health | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
AFG Biosolutions, Inc.
AFG Biosolutions, Inc. Pharmaceuticals: MajorHealth Technology Develops medical defenses against bio-terrorist agents | Health Technology |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales women's health products | Health Technology |
ContraFect Corp.
 ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
